Recomendaciones sobre el uso de metrotexato parenteral en enfermedades reumáticas-Reference-Cited by-同舟云学术

Recomendaciones sobre el uso de metrotexato parenteral en enfermedades reumáticas

Published:2018-05 Issue:3 Volume:14 Page:142-149
ISSN:1699-258X
Container-title:Reumatología Clínica
language:es
Short-container-title:Reumatología Clínica

Author:

Tornero Molina Jesús,Calvo Alen Jaime,Ballina Javier,Belmonte María Ángeles,Blanco Francisco J.,Caracuel Miguel Ángel,Carbonell Jordi,Corominas Héctor,Chamizo Eugenio,Hidalgo Cristina,Ivorra José Román,Marenco José Luis,Moreno Muelas José Vicente,Muñoz-Fernández Santiago,Nolla Joan M.,Pérez Trinidad,Sanmarti Raimon,Trenor Pilar,Urrego Claudia,Vidal Javier,Rosas Gomez de Salazar José

Publisher

Elsevier BV

Subject

Rheumatology

Reference52 articles.

1. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: A systematic review of the literature;Visser;Ann Rheum Dis.,2009

2. Optimizing methotrexate therapy in rheumatoid arthritis: A systematic literature review;Mouterde;Joint Bone Spine.,2011

3. Safety of synthetic and biological DMARDs: A systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis;Ramiro;Ann Rheum Dis.,2014

4. Recommendations for the use of methotrexate in rheumatoid arthritis: Up and down scaling of the dose and administration routes;Tornero Molina;Reumatol Clin.,2015

5. 2014 update of the consensus statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis;Sanmarti;Reumatol Clin.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial Treatment with Biological Therapy in Rheumatoid Arthritis;Journal of Clinical Medicine;2023-12-21

2. Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review;Arthritis Care & Research;2023-06-12

3. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis;Reumatología Clínica (English Edition);2022-01

4. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis;Reumatología Clínica;2022-01

5. Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review;Drug, Healthcare and Patient Safety;2021-03